In the lymphoma xenograft study, we found that EL-4 cells, syngeneic to C57BL/6 mice, form rapidly growing xenografts that are pharmacologically responsive to CHOP-based treatment in hCAR-TG mice. Here, CXADR is linked to lymphoma.